Abstract:The first- and second-generation clinically used HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) are key components of antiretroviral therapy (ART), which work by blocking the integration step in the HIV-1 replication cycle that is catalyzed by a nucleoprotein assembly called an intasome. However, resistance to even the latest clinically used INSTIs is beginning to emerge. Developmental third-generation INSTIs, based on naphthyridine scaffolds, are promising candidates to combat drug-resistant viral variants. Among these novel INSTIs, compound 4f exhibits two distinct conformations when binding with intasomes from HIV-1 and the closely related prototype foamy virus (PFV) despite the high structural similarity of their INSTI binding pockets. The molecular mechanism and the key active site residues responsible for these differing binding modes in closely related intasomes remain elusive. To unravel the molecular determinants governing the two distinct binding modes, we applied a novel molecular dynamics-based free energy method that utilizes alchemical pathways to overcome the sampling challenges associated with transitioning between the two bound conformations of ligand 4f within the crowded environments of the INSTI binding pockets in these intasomes. The calculated conformational free energies successfully recapitulate the experimentally observed binding mode preferences in the two viral intasomes. Analysis of the simulated structures suggests that the observed binding mode preferences are caused by amino acid residue differences in both the front and the central catalytic sub-pocket of the INSTI binding site in HIV-1 and PFV. Additional free energy calculations on mutants of HIV-1 and PFV revealed that while both sub-pockets contribute to binding mode selection, the central sub-pocket plays a more important role. These results highlight the importance of both side chain and solvent reorganization, as well as the conformational entropy in determining the ligand binding mode, and will help inform the development of more effective INSTIs for combatting drug-resistant viral variants.

Investigation of Formation of Dimeric G-quadruplex of HIV-1 Integrase Inhibitor by Nuclear Magnetic Resonance

Investigation of Formation, Recognition, Stabilization, and Conversion of Dimeric G-quadruplexes of HIV-1 Integrase Inhibitors by Electrospray Ionization Mass Spectrometry

An Interlocked Dimeric Parallel-Stranded DNA Quadruplex: A Potent Inhibitor of HIV-1 Integrase

Collision-induced Dissociation of Dimeric G-quadruplexes of HIV-1 Integrase Inhibitors and Their Complexes by Tandem-in-time Mass Spectrometry.

Research Progress of HIV-1 Integrase and Its Inhibitors

HIV-1 Nucleocapsid Proteins as Molecular Chaperones for Tetramolecular Antiparallel G-Quadruplex Formation

Investigation of interaction of HIV-1 DNA and polyamides, imide derivatives by electrospray ionization mass spectrometry

Formation and Recognition of G-Quadruplex Relevant for Pilin Antigenic Variation in Neisseria Gonorrhoeae

Structural elucidation of HIV-1 G-quadruplexes in cellular environment and their ligand binding using responsive 19 F-labeled nucleoside probes

Investigation of the interaction between HIV-1 DNA and cyclic peptides by electrospray ionization mass spectrometry

Investigation of Non-Covalent Complexes of Hiv-1 Promoter Dna and Polyamides Containing N-Methylpyrrole by Electrospray Ionization Mass Spectrometry

Unambiguous Detection of LTR-III G-Quadruplex in the HIV Genome Using a Tailored Fluorogenic Probe-based Assay

Specific Recognition of Human Telomeric G-Quadruplex Dna with Small Molecules and the Conformational Analysis by Esi Mass Spectrometry and Circular Dichroism Spectropolarimetry

Formation of an Interlocked Quadruplex Dimer by D(gggt)

G-quadruplex formation in double strand DNA probed by NMM and CV fluorescence

Quantitative Structure-Activity Relationships of Hiv-1 Integrase Inhibitors of Dkas

AMOEBA Polarizable Molecular Dynamics Simulations of Guanine Quadruplexes: from the c-Kit Proto-oncogene to HIV-1

Irreversible Inhibition of Human Immunodeficiency Virus Type 1 Integrase by Dicaffeoylquinic Acids.

Formation and stability of G-quadruplexes self-assembled from guanine-rich strands.

Elucidating the Molecular Determinants of the Binding Modes of a Third-Generation HIV-1 Integrase Strand Transfer Inhibitor: The Importance of Side Chain and Solvent Reorganization

In Vitro Selection of G-Rich Rna Aptamers That Target Hiv-1 Integrase